Early versus late third trimester maternal SARS-CoV-2 BNT162b2 mRNA immunization maximizes transplacental antibody transfer and neonatal neutralizing antibody levels

Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, Dana G. Wolf, Shay Porat
doi: https://doi.org/10.1101/2021.08.30.21262875

Data Availability

Individual-level data will not be made publicly available with this Article. Requests for sharing of deidentified individual-level participant data for scientific research can be directed to the corresponding authors. All proposals will be subject to scientific review and institutional review board approval at Hadassah Medical Center.

Back to top
Posted September 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Early versus late third trimester maternal SARS-CoV-2 BNT162b2 mRNA immunization maximizes transplacental antibody transfer and neonatal neutralizing antibody levels
Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, Dana G. Wolf, Shay Porat
medRxiv 2021.08.30.21262875; doi: https://doi.org/10.1101/2021.08.30.21262875
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area